David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.91% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Healthcare | 10.16% |
| 5 | Financials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
CALL
Progressive
PGR
$127B
| $3.62M | ﹤0.01% |
50,000
+30,000
| +150% | +$2.16M |
|
1952
Kura Oncology
KURA
$1.15B
| $3.62M | ﹤0.01% |
263,220
+67,322
| +34% | +$998K |
|
1953
CALL
Truist Financial
TFC
$61.5B
| $3.6M | ﹤0.01% |
64,000
+20,000
| +45% | +$1.08M |
|
1954
WaFd
WAFD
$2.66B
| $3.6M | ﹤0.01% |
98,105
+39,543
| +68% | +$1.45M |
|
1955
Children's Place
PLCE
$58.3M
| $3.59M | ﹤0.01% |
57,377
-127,803
| -69% | -$9.32M |
|
1956
PUT
Macerich
MAC
$6.88B
| $3.58M | ﹤0.01% |
133,100
+44,700
| +51% | +$1.23M |
|
|
AUY
1957
DELISTED
Yamana Gold, Inc.
AUY
| $3.58M | ﹤0.01% |
905,193
-751,061
| -45% | -$2.64M |
|
1958
Hanover Insurance
THG
$7.91B
| $3.58M | ﹤0.01% |
26,185
-22,605
| -46% | -$3.04M |
|
1959
Tenet Healthcare
THC
$21.7B
| $3.58M | ﹤0.01% |
94,067
-248,429
| -73% | -$7.44M |
|
1960
Pacific Biosciences
PACB
$485M
| $3.58M | ﹤0.01% |
695,814
+310,358
| +81% | +$1.58M |
|
1961
Fastly Inc
FSLY
$3.88B
| $3.58M | ﹤0.01% |
178,148
+98,336
| +123% | +$2.07M |
|
1962
Tetra Tech
TTEK
$9.38B
| $3.58M | ﹤0.01% |
207,475
-139,965
| -40% | -$2.42M |
|
1963
PUT
Dollar Tree
DLTR
$24.8B
| $3.57M | ﹤0.01% |
+38,000
| New | +$3.99M |
|
1964
PUT
Chemed
CHE
$7.11B
| $3.56M | ﹤0.01% |
8,100
+4,100
| +103% | +$1.72M |
|
1965
Essent Group
ESNT
$6.22B
| $3.56M | ﹤0.01% |
68,406
+24,655
| +56% | +$1.29M |
|
1966
EPAM Systems
EPAM
$5.9B
| $3.55M | ﹤0.01% |
16,735
+11,252
| +205% | +$2.21M |
|
1967
CALL
O'Reilly Automotive
ORLY
$71.3B
| $3.55M | ﹤0.01% |
121,500
| – | – |
|
1968
Becton Dickinson
BDX
$51.8B
| $3.55M | ﹤0.01% |
13,377
-32,298
| -71% | -$8.05M |
|
1969
CALL
Stanley Black & Decker
SWK
$15.1B
| $3.55M | ﹤0.01% |
21,400
-20,000
| -48% | -$3.1M |
|
1970
PUT
Qorvo
QRVO
$8.41B
| $3.54M | ﹤0.01% |
+30,500
| New | +$2.95M |
|
|
CTRA
1971
PUT
DELISTED
Coterra Energy
CTRA
| $3.54M | ﹤0.01% |
+203,400
| New | +$3.53M |
|
|
EBIX
1972
PUT
DELISTED
Ebix Inc
EBIX
| $3.54M | ﹤0.01% |
106,000
-37,200
| -26% | -$1.37M |
|
|
GWPH
1973
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $3.54M | ﹤0.01% |
33,828
+25,744
| +318% | +$2.89M |
|
1974
CALL
Broadridge
BR
$21B
| $3.53M | ﹤0.01% |
28,600
| – | – |
|
1975
CALL
Mondelez International
MDLZ
$80.3B
| $3.52M | ﹤0.01% |
63,900
-110,000
| -63% | -$5.88M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.